PapersPMID:39256461
Comparative study of safflower yellow adjuvant to conventional treatment regimen and conventional treatment regimen on diabetic nephropathy.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
What moved
How to read these marks →- Decreases fasting blood glucose
moderate
“The result showed that the level of FBG was significantly decreased in safflower yellow adjuvant to conventional treatment group compared with conventional treatment group (MD = 0.40, 95%CI 0.05 to 0.75; Fig. 3A).”
- Effect
- 0.4 mean difference, 95% CI 0.05 to 0.75
- Population
- Patients with early diabetic nephropathy and type 2 diabetes; 14 pooled randomised trials of safflower yellow added to conventional treatment versus conventional treatment, with background drugs given to both arms in many trials
“The results suggested that the total efficacy rate in safflower yellow adjuvant to conventional treatment group was higher than that in conventional treatment group (RR = 1.28, 95%CI 1.21 to 1.36; Fig. 3E).”
- Effect
- 1.28 risk ratio, 95% CI 1.21 to 1.36
- Population
- Patients with early diabetic nephropathy and type 2 diabetes; 15 pooled randomised trials of safflower yellow added to conventional treatment versus conventional treatment, with background drugs given to both arms in many trials
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Patients with early diabetic nephropathy and type 2 diabetes; 28 Chinese randomised trials of safflower yellow (extract of safflower petals) added to conventional treatment
- Participants
- 2,251
- Comparator
- no treatment
- Duration
- not reported
- Endpoints measured
- 13